COMMUNIQUÉS West-GlobeNewswire

IntelGenx Announces Notice of Grant of European Patent Covering Rizaport® VersaFilm™
19/06/2018
SAINT LAURENT, Quebec, June 19, 2018 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (the “Company” or “IntelGenx”) today announced that the European Patent Office (“EPO”) has issued a “Notice of Intention [...]
CymaBay Therapeutics to Host Analyst and Investor Day on June 26, 2018
19/06/2018
NEWARK, Calif., June 19, 2018 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ:CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet [...]
Aphios and LSU Health Shreveport Inventors Granted Patent to Improve Transplantation
19/06/2018
WOBURN, Mass., June 19, 2018 (GLOBE NEWSWIRE) -- Aphios Corporation today announced that it and the LSU Health Shreveport Department of Molecular & Cellular Physiology have been granted United States Patent No. 9, [...]
Allena Pharmaceuticals Completes Animal Proof-of-Concept Study for ALLN-346, Lead Product Candidate for Hyperuricemia in the Setting of Advanced Chronic Kidney Disease
19/06/2018
-- ALLN-346, a Novel, Engineered, Urate Oxidase, Demonstrates Robust Reduction of Plasma and Urine Uric Acid After Oral Administration in an Animal Model of Hyperuricemia -- -- Data Supports Advancement of ALLN-346 as [...]
Catalyst Biosciences to Present at the JMP Securities 2018 Life Sciences Conference
19/06/2018
SOUTH SAN FRANCISCO, Calif., June 19, 2018 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (Nasdaq:CBIO), a clinical-stage biopharmaceutical company focused on developing novel medicines to address hematology indications [...]
7 Hills Pharma Launches With $2 Million SBIR Grant in Addition to $4 Million in Seed Capital to Pursue Novel Cancer Therapeutics to Promote a Productive Immune Response and Overcome Drug Resistance
19/06/2018
Stealth start-up company debuts with support from NIH and Leading Immuno-Oncology Experts HOUSTON, June 19, 2018 (GLOBE NEWSWIRE) -- 7 Hills Pharma, a privately-held immunotherapy company focused on development of novel [...]
Tetra Bio-Pharma Adds a New Leader for its Commercial Operations
19/06/2018
Tetra Natural Health and Tetra Veterinary Health ORLEANS, Ontario, June 19, 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc ., a leader in cannabinoid-based drug discovery and development (TSX VENTURE:TBP) (OTCQB:TBPMF), [...]
IRIDEX Announces Approval of CYCLO G6™ Glaucoma Laser System in Korea
19/06/2018
MOUNTAIN VIEW, Calif., June 19, 2018 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq:IRIX) today announced the approval of its CYCLO G6™ Glaucoma Laser system by South Korea's Ministry of Food and Drug Safety (MFDS). [...]
Arch Biopartners to Seek Regulatory Guidance From the U.S FDA for AB569
19/06/2018
TORONTO, June 19, 2018 (GLOBE NEWSWIRE) -- Arch Biopartners, Inc., (Arch or the Company) (TSX-V:ARCH) (OTCBB:ACHFF) a portfolio-based biotechnology company, today announced that it will seek regulatory guidance from the [...]
Matinas BioPharma Announces Pricing of $8.0 Million Public Offering
19/06/2018
BEDMINSTER, N.J., June 19, 2018 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER:MTNB), a clinical-stage biopharmaceutical company focused on enabling the delivery of life-changing medicines using its [...]
Precipio Updates Commercial Pipeline for its ICE-COLD PCR™ Liquid Biopsy Technology
19/06/2018
Trials underway at five laboratories and two diagnostic equipment companies NEW HAVEN, Conn., June 19, 2018 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO), today detailed its [...]
Marinus Pharmaceuticals Initiates Pivotal Phase 3 Trial in Children with CDKL5 Deficiency Disorder
19/06/2018
Marigold Study targets rare form of pediatric epilepsy with no approved therapies RADNOR, Pa., June 19, 2018 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS) (“Marinus” or “Company”), a biopharmaceutical [...]
VitalHub Announces Two New Deals for VH LTC Solution
19/06/2018
TORONTO, June 19, 2018 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSX-V:VHI) is pleased to announce two new sales of its VH LTC solution. The VH LTC solution is designed specifically for Long-Term [...]
Leading BioSciences Reports Positive Interim Results from Phase 2 Trial of LB1148 in Patients Undergoing Major Surgery
19/06/2018
Novel Gastroprotective Treatment Demonstrates 3.2 Day Decrease in Hospital Length of Stay Following Surgery Compared to Placebo; LB1148 Triggers Statistically Significant 18-Hour Improvement in Post-Operative Return to [...]
MediWound Expands Its NexoBrid® Phase 3 Children Innovation Debridement Study (CIDS) to the U.S.
19/06/2018
Study fully funded by BARDA YAVNE, Israel, June 19, 2018 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq:MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn [...]
NeuroMetrix Receives $3.8M Milestone Payment Under Its Collaboration with GSK Consumer Healthcare
19/06/2018
WALTHAM, Mass., June 19, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO), today reported that it had achieved the first development milestone under its strategic collaboration with GSK Consumer Healthcare. A [...]
U.S. Department of Defense to Study Pluristem’s PLX-R18 for the Treatment of Mustard Gas Injuries
19/06/2018
Studies to be funded by the U.S. NIH Marks the second project for DOD with PLX-R18 cell therapy product HAIFA, Israel, June 19, 2018 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading [...]
Zomedica Provides Product Development Update
19/06/2018
ANN ARBOR, Mich., June 19, 2018 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V:ZOM) (“Zomedica” or the “Company”), a veterinary diagnostic and pharmaceutical company, today provided a [...]
U.S. Healthcare Leader Joseph R. Swedish Joins Mesoblast Board
19/06/2018
NEW YORK and MELBOURNE, Australia, June 19, 2018 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO) (ASX:MSB) today announced that Joseph R. Swedish has joined its Board of Directors. Mr. Swedish has more than two [...]

Pages